M&A Deal Summary

BioVaxys Technology Acquires TAETSoftware

On March 16, 2023, BioVaxys Technology acquired software company TAETSoftware

Acquisition Highlights
  • This is BioVaxys Technology’s 1st transaction in the Software sector.
  • This is BioVaxys Technology’s 1st transaction in Canada.
  • This is BioVaxys Technology’s 1st transaction in British Columbia.

M&A Deal Summary
Date 2023-03-16
Target TAETSoftware
Sector Software
Buyer(s) BioVaxys Technology
Deal Type Add-on Acquisition

Target

TAETSoftware

Vancouver, British Columbia, Canada
TAETSoftware is a clinical studies management company engaged in the development and commercialization of the Trial Adverse Events Tracker ("TAET") technology platform, a proprietary software application which will enable clinical study subjects to record and submit clinical trial Adverse Drug Events ("ADE") reports to study sponsors in real time. TAETSoftware was founded in 2005 and is based in Vancouver, British Columbia.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioVaxys Technology

Vancouver, British Columbia, Canada
Category Company
Sector Life Science
DESCRIPTION

BioVaxys Technology is a clinical stage biotechnology company that is developing viral and oncology vaccine platforms, as well as immuno-diagnostics. BioVaxys Technology is based in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2023) 1 of 1
Mergr

Product

Company

Legal